Filing Details

Accession Number:
0001140361-17-043114
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-11-16 16:53:09
Reporting Period:
2017-11-14
Accepted Time:
2017-11-16 16:53:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1444380 Nevro Corp NVRO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1417976 H Andrew Galligan C/O Nevro Corp.
1800 Bridgeway Parkway
Redwood City CA 94065
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-11-14 13,000 $0.00 28,192 No 4 A Direct
Common Stock Acquisiton 2017-11-14 7,000 $18.00 35,192 No 4 M Direct
Common Stock Disposition 2017-11-14 7,000 $75.11 28,192 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2017-11-14 26,000 $0.00 26,000 $76.81
Common Stock Stock Option (Right to Buy) Disposition 2017-11-14 7,000 $0.00 7,000 $18.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
26,000 2027-11-13 No 4 A Direct
35,463 2024-11-04 No 4 M Direct
Footnotes
  1. Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 25% of the RSUs vest annually on November 1 of each year, beginning November 1, 2018, subject to the Reporting Person's continued service to the issuer.
  2. Includes 18,125 RSUs.
  3. The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  4. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.00 to $75.38, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
  5. 1/48th of the shares subject to the option vest on each monthly anniversary measured from November 14, 2017 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
  6. 1/48th of the shares subject to the option vest on each monthly anniversary measured from November 5, 2014 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.